Fluorouracil and Dose-Dense Chemotherapy in Adjuvant Treatment of Patient with Early-Stage Breast Cancer: an Open-Label, 2 x 2 Factorial, Randomised Phase III Trial

被引：0
|
作者：
Colle, E. [1 ]
Besse, B. [2 ]
机构：
[1] AERIO, Paris, France
[2] Gustave Roussy, F-94800 Villejuif, France
来源：
ONCOLOGIE | 2015年 / 17卷 / 7-8期
关键词：
METAANALYSIS;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：330 / 332
页数：3
相关论文
共 50 条
  • [21] Dose-dense adjuvant chemotherapy in patients with HER2-low early breast cancer: An exploratory analysis of the GIM2 trial
    Molinelli, Chiara
    Delucchi, Virginia
    Blondeaux, Eva
    Boni, Luca
    Poggio, Francesca
    Arpino, Grazia
    Nistico, Cecilia
    Fabi, Alessandra
    De laurentiis, Michelino
    Puglisi, Fabio
    Marta, Guilherme Nader
    Fozza, Alessandra
    Pitto, Francesca
    Lambertini, Matteo
    Del Mastro, Lucia
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [22] Phase I/II trial of adjuvant dose-dense docetaxel/epirubicin/cyclophosphamide (TEC) in stage II and III breast cancer
    Burdette-Radoux, Susan
    Wood, Marie E.
    Olin, Julie J.
    Laughlin, Rebecca S.
    Crocker, Abigail M.
    Ashikaga, Takamaru
    Muss, Hyman B.
    BREAST JOURNAL, 2007, 13 (03): : 274 - 280
  • [23] Correction to: Phase 2 Open-Label Trial Investigating Percutaneous Laser Ablation for Treatment of Early-Stage Breast Cancer: MRI, Pathology, and Outcome Correlations
    Barbara Schwartzberg
    John Lewin
    Osama Abdelatif
    Jacqueline Bernard
    Hanadi Bu-Ali
    Simon Cawthorn
    Margaret Chen-Seetoo
    Sheldon Feldman
    Sasirekha Govindarajulu
    Lyn Jones
    Arne Juette
    Sanjay Kavia
    Robert Maganini
    Simon Pain
    Mike Shere
    Craig Shriver
    Simon Smith
    Alexandra Valencia
    Eric Whitacre
    Roger Whitney
    Annals of Surgical Oncology, 2018, 25 : 998 - 998
  • [24] Feasibility Trial of Partial Breast Irradiation With Concurrent Dose-Dense Doxorubicin and Cyclophosphamide in Early-Stage Breast Cancer
    Zellars, Richard C.
    Stearns, Vered
    Frassica, Deborah
    Asrari, Fariba
    Tsangaris, Theodore
    Myers, Lee
    DiPasquale, Shirley
    Lange, Julie R.
    Jacobs, Lisa K.
    Emens, Leisha A.
    Armstrong, Deborah K.
    Fetting, John H.
    Garrett-Mayer, Elizabeth
    Davidson, Nancy E.
    Wolff, Antonio C.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (17) : 2816 - 2822
  • [25] A randomized, open-label CECOG phase II study of dose-dense FEC 75 vs FEC 90 as adjuvant therapy in early breast cancer patients
    Kahan, S.
    Spanik, S.
    Wagnerova, M.
    Skacel, T.
    Planko, B.
    Fitzthum, E.
    Lindner, E.
    Soldatenkova, V.
    Zielinski, C. C.
    Brodowicz, T.
    EJC SUPPLEMENTS, 2007, 5 (04): : 211 - 212
  • [26] Adjuvant dose-dense doxorubicin plus cyclophosphamide followed by dose-dense nab-paclitaxel is safe in women with early-stage breast cancer: a pilot study
    Nicholas Robert
    Lea Krekow
    Chris Stokoe
    Alicia Clawson
    Jose Iglesias
    Joyce O’Shaughnessy
    Breast Cancer Research and Treatment, 2011, 125 : 115 - 120
  • [27] Adjuvant phase III trial to compare intense dose-dense adjuvant treatment with EnPC to dose dense, tailored therapy with dtEC-dtD for patients with high-risk early breast cancer (GAIN-2)
    Moebus, Volker
    Forstbauer, Helmut
    Wachsmann, Grischa
    Schneeweiss, Andreas
    Ober, Angelika
    von Abel, Ekkehard
    Krabisch, Petra
    Hoeffkes, Heinz-Gert
    Kast, Karin
    Christensen, Bernd
    Niedermeier, Michael
    Daryal, Mustafa
    Uleer, Christoph
    Fauster, Yvonne
    Goehler, Thomas
    Loibl, Sibylle
    Nekljudova, Valentina
    von Minckwitz, Gunter
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [28] Partial breast irradiation (PBI) concurrent with adjuvant dose-dense doxorubicin and cyclophosphamide (ddAC) chemotherapy in early-stage breast cancer: Preliminary safety results from a feasibility trial
    Zellars, R.
    Frassica, D.
    Stearns, V.
    Fetting, J.
    Armstrong, D.
    Myers, L.
    Tsangaris, T.
    Jacob, L.
    Lange, J.
    Wolff, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : S217 - S218
  • [29] Adjuvant dose-dense adriamycin plus cytoxan followed by dose-dense nab-paclitaxel is safe in women with early-stage breast cancer: A pilot study
    Pippen, J.
    O'Shaughnessy, J.
    Ambro, S.
    Krekow, L.
    Stokoe, C.
    Bhar, P.
    Iglesias, J.
    Robert, N.
    BREAST, 2009, 18 : S57 - S57
  • [30] Adjuvant dose-dense doxorubicin plus cyclophosphamide followed by dose-dense nab-paclitaxel is safe in women with early-stage breast cancer: a pilot study
    Robert, Nicholas
    Krekow, Lea
    Stokoe, Chris
    Clawson, Alicia
    Iglesias, Jose
    O'Shaughnessy, Joyce
    BREAST CANCER RESEARCH AND TREATMENT, 2011, 125 (01) : 115 - 120
12345